Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001225208-13-016039
Filing Date
2013-07-10
Accepted
2013-07-10 20:12:04
Documents
1
Period of Report
2012-11-01

Document Format Files

Seq Description Document Type Size
1 doc3a.html 3/A  
1 doc3a.xml 3/A 3287
  Complete submission text file 0001225208-13-016039.txt   4622
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C.O. JUNIPER NETWORKS, INC. 1194 N. MATHILDA AVE. SUNNYVALE CA 94089
Business Address
Dyckerhoff Stefan A (Reporting) CIK: 0001484394 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-50679 | Film No.: 13962780